Nevada is stepping up as a national voice for psychedelic reform. In a bold move, the state’s Senate just passed a joint resolution urging Congress to reschedule psychedelics and remove the roadblocks to researching their medical potential. This comes amid growing public interest and scientific backing for psychedelic-assisted therapies.
The resolution calls on the federal government to reclassify psychedelics like psilocybin and MDMA, which are currently labeled as Schedule I substances—meaning they’re considered to have no medical use and a high risk of abuse. This outdated classification makes it nearly impossible for researchers to conduct studies, despite mounting evidence of the benefits these substances may offer for mental health conditions like PTSD, depression, and anxiety.
By rescheduling psychedelics, Nevada lawmakers hope to spark more scientific breakthroughs and provide new pathways for treatment, especially for veterans and others who have exhausted conventional options. This effort mirrors a nationwide shift, as states like Colorado and Oregon already move forward with psychedelic policy reform. Nevada’s approach, however, keeps the focus on science—pushing for data-driven decisions at the federal level.
While the resolution doesn’t legalize psychedelics, it sends a clear message: criminalization shouldn’t stand in the way of healing. Lawmakers are starting to see these substances not as threats, but as tools—with the potential to revolutionize mental health care when studied and used responsibly.
High Science supports advancing research that prioritizes public health and scientific integrity. Nevada’s call to action is one more step toward a future where access to healing is guided by evidence, not fear.
For more on topics like these, check this link out ARIZONA EASES MARIJUANA USE RESTRICTIONS FOR POLICE RECRUITS ONCE AGAIN
